SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 22, 15:55
2899.25
0.2 (0.01%)
VOLUME 30,292
LIVE
NSE
Feb 22, 15:55
2903.20
9.15 (0.32%)
VOLUME 856,440
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Six in Sixty: Stocks you should keep on your radar 

2.52 pm | 22 Feb 2017 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on....

Dr Reddy's receives 3 USFDA observations for Miryalaguda plant

11.27 am | 22 Feb 2017 |  Source: Moneycontrol.com

The company didn’t explain the nature of these observations. Miryalaguda plant was one among the three plants for which the company got US drug regu...

Buy, sell, hold: 8 stocks to watch out for your portfolio

10.37 am | 22 Feb 2017 |  Source: Moneycontrol.com

Morgan Stanley feels any interest in Axis Bank will be based on its retail franchise as it is one of the few banks with a strong retail deposit franch...

Stocks in news: Dr Reddy's, ITC, TCS, BEL, Axis, BPCL, Disa, ITD

8.00 am | 22 Feb 2017 |  Source: CNBC-TV18

Dr Reddy's Labs | ITC | Infosys | TCS | Tata Motors | Bharat Electronics | Power Grid | Axis Bank | ONGC | HPCL | BPCL | Castrol India | Castex Techno...

Dr Reddy's Miryalaguda facility gets 3 USFDA observations 

9.10 pm | 21 Feb 2017 |  Source: PTI

Drug firm Dr Reddy's Laboratories today said the US health regulator has made three observations after completing inspection of its Miryalaguda faci...

Sell Havells, Dr Reddy's; buy Petronet, Siemens: Sukhani 

10.19 am | 20 Feb 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Havells India and Dr Reddy's Labs and advises buying Petronet LNG and Siemens....

Buy, sell, hold: 7 stocks analysts are watching out

9.48 am | 20 Feb 2017 |  Source: Moneycontrol.com

Goldman Sachs says Kotak Mahindra Bank may outperform on improving growth prospects & top quartile EPS growth. Lending book is likely to grow at 25 pe...

Six in Sixty: Stocks you should keep on your radar 

2.56 pm | 16 Feb 2017 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists six stocks that you should focus on – Infosys, Tata Consultancy Services (TCS), Dr Reddys Laboratories, Sun Pharmaceuti...

Top buzzing midcap stocks to trade on February 16 

1.30 pm | 16 Feb 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today – Dr Reddys, TCS, Fortis Health, SBI and IL&FS Engineering....

Buy Dr Reddy’s Laboratories 2850 Put: Mitessh Thakkar 

11.52 am | 16 Feb 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com is of the view that one can buy Dr Reddy’s Laboratories 2850 Put while he feels that the trend in Tata Motors D...

DRL gets adverse ruling in US over patent infringement case

11.14 am | 16 Feb 2017 |  Source: PTI

In a BSE filing, Reddy's Laboratories said: "The United States District Court for the District of New Jersey issued its opinion regarding Helsinn Heal...

Dr Reddy's gets unfavourable ruling in US over anti-nausea drug 

10.31 am | 16 Feb 2017 |  Source: Moneycontrol.com

Dr Reddy's on Thursday said it received an unfavorable ruling in a US court regarding a patent infringement case over its anti-nausea injection Aloxi....

Dr Reddy's Lab announces US district court's opinion relating to patent infringement

10.03 am | 16 Feb 2017 |  Source: Moneycontrol.com

Dr Reddys announced that the United States District Court for the district of New Jersey issued it opinion regarding Helsinn Healthcares patent infr...

FIIs' stake in Nifty cos at 6-quarter low in Q3; Infosys dumped

3.18 pm | 15 Feb 2017 |  Source: Moneycontrol.com

Foreign institutional investors (FIIs) pared their equity holdings in frontline Indian companies during the December quarter, with market watchers bla...

Dr Reddy's, Aurobindo recall drugs from US market

2.40 pm | 15 Feb 2017 |  Source: PTI

According to a notification issued by the US Food and Drug Authority, Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is reca...

Cipla joins the race to build specialty branded business in US

4.56 pm | 13 Feb 2017 |  Source: Moneycontrol.com

Cipla will be falling back on its core strengths in respiratory and central nervous system (CNS) for build-up of specialty pipeline in US. The company...

See at least two US Fed rate hikes this year: Sanjeev Prasad 

11.05 am | 13 Feb 2017 |  Source: CNBC-TV18

The strength of the US dollar will decide the fate of the emerging markets (EMs), said Sanjeev Prasad, Senior ED & Co-Head at Kotak Institutional Equi...

Dr Reddy's launches generic drugs in France; expands Ops in

2.42 pm | 10 Feb 2017 |  Source: PTI

According to a recently issued statement, the products will be made available in the hospital market in March this year in the area of oncology and an...

Hold Dr Reddy's Lab; target of Rs 2970: Centrum

2.38 pm | 10 Feb 2017 |  Source: Moneycontrol.com

Centrum recommended hold rating on Dr Reddy's Lab with a target price of Rs 2970 in its research report dated February 06, 2017....

Aurobindo forays into biosimilars with Swiss acquisition

10.30 pm | 09 Feb 2017 |  Source: Moneycontrol.com

Aurobindo Pharma forayed into biosimilars with acquisition of four cell culture derived biosimilar products from Switzerland-based TL Biopharmaceutica...

1 2 3 4 5 6
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.